Hleðsla

Slzii.com Leita

Leita (Fréttir)

Milestone Wins NMPA Approval For Etripamil Nasal Spray In PSVT

Rttnews english business

Milestone Pharmaceuticals Inc. (Nasdaq: MIST) announced that the China National Medical Products Administration (NMPA) has approved CARDAMYST (Etripamil) nasal spray for the treatment of paroxysmal supraventricular tachycardia.
2026-09-03 14:31:28

Hvað ertu að gera?
0.030419826507568


Fréttir
Rttnews

Nýjustu fréttir og fyrirsagnir
Milestone Pharmaceuticals Inc. (Nasdaq: MIST) announced that the China National Medical Products Administration (NMPA) has approved CARDAMYS...
Fréttir